Is National Fabry Disease Foundation Legit?

The National Fabry Disease Foundation demonstrates a generally stable financial position, with assets consistently exceeding liabilities (which are reported as $0 across all available filings). Revenue has fluctuated significantly year-to-year, ranging from a low of $188,701 in 2021 to a high of $572,188 in 2022, indicating a reliance on variable funding sources. The organization's spending efficiency appears to be a mixed bag; in some years, like 2022, revenue significantly outpaced expenses ($572,188 vs. $228,527), leading to substantial asset growth. However, in other years, such as 2023, expenses exceeded revenue ($472,698 vs. $307,957), resulting in a draw-down of assets. The consistent reporting of $0 liabilities and 0% officer compensation across all filings suggests a commitment to financial transparency and a lean operational structure regarding executive pay. However, without a detailed breakdown of program, administrative, and fundraising expenses, a precise assessment of spending efficiency is challenging. The organization's asset base has shown growth over time, from $133,009 in 2017 to $521,056 in 2023, indicating a healthy accumulation of resources. The absence of reported liabilities is a strong positive indicator of financial stability. While the revenue volatility could pose planning challenges, the foundation has managed to maintain a positive asset position. The lack of officer compensation further reinforces a perception of efficient use of funds, potentially relying on volunteer leadership or very modest stipends not categorized as officer compensation. To fully assess spending efficiency, a more granular breakdown of expenses would be beneficial.